Oral Polio Vaccine (OPV): Advantages, Risks, and Role in Global Eradication
OPV (Sabin) uses live-attenuated poliovirus (types 1, 2, 3) administered orally. It has been instrumental in global polio eradication efforts.
Key Advantages
- Ease of Delivery: No needles; cold chain simpler than IPV; community health workers can administer.
- Mucosal Immunity: Induces secretory IgA in the gut, blocking fecal-oral transmission (critical for eradication).
- Herd Immunity: Vaccine virus spreads to contacts, amplifying population immunity.
- Cost: ~$0.15–0.20/dose vs. IPV $1–3.
- Rapid Protection: Single dose induces immunity within days.
Critical Risk: VAPP
- Vaccine-associated paralytic poliomyelitis: ~1 case per 2.7 million doses (first dose higher risk).
- Immunodeficiency can lead to prolonged excretion and vaccine-derived poliovirus (VDPV) emergence.
Global Policy Shift
- 2016 "The Switch": Trivalent OPV (tOPV) → bivalent OPV (bOPV, types 1+3 only) after type 2 eradication certified.
- Endgame: Sequential IPV → OPV cessation. IPV now in routine immunization globally; OPV reserved for outbreak response (mOPV2, nOPV2).
- nOPV2 (novel OPV type 2): Genetically stabilized, lower reversion risk.
OPV remains essential for outbreak control in endemic/outbreak zones despite VAPP risk.
Folk Medicine - Related Articles
- Santé: The French Word for Health and a Universal Toast
- Homophones of 'Patients': Understanding the Differences
- Natural Toenail Fungus Treatment: Home Remedies & Prevention
- English vs. Roman Chamomile: A Comprehensive Guide
- Amish Home Remedies: Traditional & Effective Solutions
- Vinegar & Baking Soda: Natural Remedies & Health Benefits
- Natural Healing: Exploring Traditional Food Remedies
